Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 3/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.34 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22779178 | 1.00 | SLC6A9 (0.42) | SLC6A9PTGS1PTGS2ALBTACR1 | |
| SCHEMBL19016167 | 0.94 | SLC6A9 (0.38) | SLC6A9PTGS1PTGS2ALBTACR1 | |
| SCHEMBL23014569 | 0.84 | ALB (0.52) | SLC6A9PTGS1PTGS2ALBALDH1A1 | |
| SCHEMBL24728937 | 0.84 | ALB (0.52) | SLC6A9PTGS1PTGS2ALBALDH1A1 | |
| SCHEMBL15362876 | 0.84 | ALB (0.51) | SLC6A9PTGS1PTGS2ALBALDH1A1 | |
| SCHEMBL23762982 | 0.84 | ALB (0.51) | SLC6A9PTGS1PTGS2ALBALDH1A1 | |
| SCHEMBL9094862 | 0.82 | ALB (0.54) | ALB | |
| SCHEMBL16922674 | 0.81 | SLC6A9 (0.43) | SLC6A9ALBTACR1CACNA2D1CACNA1B | |
| SCHEMBL15362897 | 0.79 | ALB (0.47) | SLC6A9PTGS1PTGS2ALBALDH1A1 | |
| SCHEMBL19016237 | 0.77 | ALB (0.35) | SLC6A9ALBTACR1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230127047-A1 | SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES | ANTAROS MEDICAL AB (SE) | 2023-04-27 | — | — | US | disclosed |
| US-20230127047-A1 | SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES | ANTAROS MEDICAL AB (SE) | 2023-04-27 | — | — | US | disclosed |
| WO-2021198229-A1 | SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES | ANTAROS MEDICAL AB (SE) | 2021-10-07 | — | — | WO | disclosed |
| US-11046743-B2 | Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes | ANTAROS MEDICAL AB (SE) | 2021-06-29 | — | — | US | disclosed |
| US-20200262885-A1 | SELECTIVE GLUCAGON RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING PURPOSES | ANTAROS MEDICAL AB (SE) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127047-A1 | SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES | GIPR, GRPR, GLP1R | SLC6A9 934/4885PTGS1 3456/4885PTGS2 3855/4885 |
| US-20200262885-A1 | SELECTIVE GLUCAGON RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING PURPOSES | GLP1R, GCGR, GIPR | SLC6A9 914/4885PTGS1 3836/4885PTGS2 3986/4885 |
| US-11046743-B2 | Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes | GLP1R, GCGR, GIPR | SLC6A9 914/4885PTGS1 3836/4885PTGS2 3986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.